Introduction to compliance in medical device manufacturing
Compliance in medical device manufacturing is not just a regulatory hurdle – it’s the foundation of patient safety, market access and brand integrity. This is an industry where products can profoundly impact human lives, so rigorous adherence to regulatory requirements ensures that medical devices are safe and effective. From design to post-market monitoring, every stage demands documented evidence of compliance in medical device manufacturing.
For manufacturers, meeting compliance standards and applicable regulations is essential to protect patients, as well as to enter global markets. Regulators across different regions impose stringent rules on compliance in medical device manufacturing, and non-compliance can lead to severe consequences such as product recalls, legal liability and reputational damage.
The global regulatory environment is constantly evolving. In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) is the competent authority responsible for regulating the UK medical device market. In the EU, each member state has their own competent authority. EUDAMED (European Database on Medical Devices) is the IT system overseen by the European Commission that will become the central system for medical device registration and provide information about medical devices, and associated manufactures, available on the EU market.
At Europlaz, we offer end-to-end regulatory support tailored to the complexities of compliance in medical device manufacturing. Our expertise lies in navigating these multi-jurisdictional requirements efficiently while maintaining uncompromising quality and safety standards. We partner with clients to transform compliance in medical device manufacturing from a burden into a strategic advantage.
Core principles of regulatory compliance in medical device manufacturing
Compliance in medical device manufacturing rests on several key pillars.
These can be summarised as:
- Quality management
- Safety and performance
- Conformity assessment
- Global regulatory requirements
A robust Quality Management System (QMS) ensures structured processes across design, development, manufacturing and monitoring. ISO 13485 is the international standard for QMS in the medical device sector.
Risk management, guided by ISO 14971, plays a central role in identifying potential hazards, evaluating risks, and implementing controls.
Medical devices must be assessed to defined regulatory requirements, prior to placing the device on the market.
Global harmonisation efforts, driven by the International Medical Device Regulators Forum (IMDRF), promote alignment through international medical device regulatory harmonisation and convergence.
International compliance
Understanding and meeting the regulatory requirements of different markets is crucial for global success. Each region has distinct rules, but common principles of quality, safety and efficacy unite them.
UK regulatory requirements
In Great Britain (England, Scotland and Wales), the UK Medical Devices Regulations 2002 (SI 2002 No 618, as amended) govern the placement of devices on the market.
The UK MDR categorises medical devices into four classes: Class I, Class IIa, Class IIb and Class III, where Class I medical devices pose the lowest risk, and Class III the highest.
Under the Northern Ireland protocol, manufacturers who want to place devices on the Northern Ireland market must follow EU regulations.
Medical devices placed in the Great Britain market must have a UKCA or a CE marking, depending on which legislation the device has been certified under. Medical devices placed in the Northern Ireland market must have a CE marking.
For most medical devices (excluding Class I), CE marking is obtained through a conformity assessment by a notified body, while UKCA marking is achieved via a UK approved body. Once a device is UKCA or CE marked, a Declaration of Conformity must be made available.
General medical devices that comply with the EU MDR (CE marking) may continue to be placed on the Great Britain market until 30th June 2030.
If they are based outside the UK, manufacturers must register with the MHRA and appoint a UK Responsible Person (UKRP).
As soon as their devices are on the market, all manufacturers must implement systems to monitor their performance.
EU regulatory requirements
The EU Medical Device Regulation (MDR), 2017/745, fully applicable since May 2021, introduced significant changes to the pre-existing Medical Device Directive (MDD), 93/42/EEC.
The EU MDR categorises medical devices into four classes: Class I, Class IIa, Class IIb and Class III. Just like in the UK, Class I medical devices pose the lowest risk and Class III the highest.
For most devices – all except Class I – CE marking is achieved through conformity assessment by a notified body. Once a device is CE marked, a declaration of conformity is made available.
Manufacturers must register with the European competent authority, or on the EUDAMED database (until EUDAMED registration becomes mandatory). If based outside the EU, manufacturers require an EU authorised representative.
All devices must be assigned a Unique Device Identifier (UDI). The UDI is visible on the device and/or packaging and is a unique numeric or alphanumeric code. Its purpose is to allow for an unambiguous identification of a medical device on the market.
Manufacturers are required to have systems in place to monitor the performance of their devices once they are on the market.
Implementing a robust Quality Management System
ISO 13485 provides a comprehensive framework for implementing a medical device QMS (Quality Management System) that allows an organisation to demonstrate its ability to provide medical devices that meet applicable global regulatory requirements.
ISO 13485 considers the entire life cycle of a medical device and is intended to be used by organisations involved in one or more phases of the life cycle, such as design and development, production, storage and distribution, installation, servicing and disposal of medical devices. The standard outlines the necessary documentation, management responsibilities, resource requirements, product realisation processes, and procedures for monitoring, analysis and improvement.
Risk management and validation
Risk management is an integral part of the Quality Management System and plays a crucial role in ensuring compliance in medical device manufacturing. It involves identifying potential hazards throughout the product life cycle, assessing and controlling associated risks, and continuously monitoring for emerging issues.
ISO 14971 defines the risk management process for medical devices. The standard provides a methodology for identifying the hazards associated to a medical device, estimating and evaluating the associated risks, controlling the risks and the effectiveness of the implemented controls. The standard is applicable to the entire life cycle of the medical device.
Post-market surveillance
Post-market surveillance (PMS) is a systematic process used to proactively gather and evaluate data on a medical device once it has been placed on the market. It is designed to monitor the device’s performance, safety and effectiveness in real-world use, helping manufacturers identify any issues that may require corrective or preventive action. Effective PMS is essential for maintaining product quality and ensuring ongoing compliance in medical device manufacturing.
The PMS process requires the development of a PMS plan and, dependent on the device class, either a PMS report (Class I medical devices only) or a periodic safety update report.
Manufacturers must report serious incidents to regulatory authorities to help protect public health and ensure ongoing compliance in medical device manufacturing.
A comprehensive PMS system is built on various elements, including data collection and analysis, trend monitoring, customer feedback, complaint handling and information on both serious and non-serious incidents.
Technical documentation
To ensure compliance in medical device manufacturing, regulatory bodies require detailed technical files to be created and maintained. Key technical documentation requirements include the device description and specification, information to be supplied (e.g. labelling), design and manufacturing information, risk management, usability, product verification and validation (including sterility, biocompatibility and clinical evaluation) and post market surveillance.
These documents, among others, verify the conformity of the device to the essential requirements (UKCA) or general safety and performance requirements (CE).
The scope and requirements of the technical file will vary depending on the device type and medical device class.
Our services for compliance in medical device manufacturing
At Europlaz, we provide end-to-end solutions for compliance in medical device manufacturing. Aimed at manufacturers, our services include gap analyses, full QMS implementation, and preparation of regulatory submissions tailored to specific markets.
We follow a compliance-by-design methodology, ensuring regulatory considerations are embedded throughout the product life cycle. Our multidisciplinary team collaborates with clients to streamline processes and improve market access.
Whether you are launching a new product, or maintaining compliance for an existing one, Europlaz is your trusted partner for compliance in medical device manufacturing.
Are you ready to guarantee compliance in medical device manufacturing, with attention to detail on every stage of your medical device life cycle? Contact Europlaz today to discuss how our expert team can support your regulatory journey.
For the latest news from Europlaz, please follow us on LinkedIn.
FAQs for compliance in medical device manufacturing
How does ISO 14971 relate to compliance?
ISO 14971 outlines the risk management process. It is essential for identifying, evaluating and controlling risks throughout a device’s life cycle, forming a cornerstone of compliance.
What is the difference between CE marking and UKCA marking?
CE marking is used for devices placed on the EU and Northern Ireland markets, whereas UKCA marking is required for Great Britain following Brexit (CE marking continues to be accepted in Great Britain as an alternate route). Both confirm conformity to applicable regulations.
What is post-market surveillance (PMS)?
PMS refers to the ongoing collection and evaluation of data on a device’s performance after it has been placed on the market. It is vital for detecting and managing risks throughout the product life cycle.
